4-Methyl-1-oxaspiro(5.5)undecene
| Common Name: |
4-Methyl-1-oxaspiro(5.5)undecene |
| IUPAC Name: |
4-methyl-1-oxaspiro[5.5]undec-2-ene |
| Molecular Formula: |
C11H18O |
| SMILES: |
CC1CC2(CCCCC2)OC=C1 |
| Inchi: |
1S/C11H18O/c1-10-5-8-12-11(9-10)6-3-2-4-7-11/h5,8,10H,2-4,6-7,9H2,1H3 |
| Inchi Key: |
WJHAXQNOQJKTQV-UHFFFAOYSA-N |
| Cas No: |
68228-06-8 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
0 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
2 |
| Name |
Value |
| Molecular Weight (g/mol) |
166.26 |
| Mass (g/mol) |
166.136 |
| Molar Refractivity |
51.41 |
| Net Charge |
|
| HBD |
|
| HBA |
1 |
| Rt Bonds |
0 |
| Rings |
2 |
| TPSA |
9.23 |
| Hetero Atoms |
1 |
| Heavy Atoms |
12 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
270.00 to 271.00 |
| Vapor Pressure (mmHg@25.00 °C) |
0.043 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.82 |
| LogP |
3.259 |
| iLOGP |
2.76 |
| XLOGP3 |
3.11 |
| WLOGP |
3.26 |
| MLOGP |
2.59 |
| ESOL Log S |
-2.83 |
| ESOL Solubility (mg/ml) |
0.246 |
| ESOL Solubility (mol/l) |
0.001 |
| ESOL Class: esol_class |
Soluble |
| Ali Log S |
-2.97 |
| Ali Solubility (mg/ml) |
0.18 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Soluble |
| Silicos-IT LogSw |
-2.07 |
| Silicos-IT Solubility (mg/ml) |
1.43 |
| Silicos-IT Solubility (mol/l) |
0.01 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-5.11 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
1.07 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
1 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
1.927 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
1 |
| OCT2 inhibitor |
0 |
